EU Regulators Push Presubmission Talks for Sponsors of Orphan Drugs

Drug Industry Daily
A A
To help the European Medicines Agency (EMA) meet 90-day deadlines for orphan drug designation reviews, the agency is asking sponsors to give two months’ advance notice of their intent to file.

To View This Article:

Login

Subscribe To Drug Industry Daily